• Abraham E, Carmody A, Shenkar R, Arcaroli J. 2000. Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury. Am J Physiol Lung C 279: L1137L1145.
  • Bao ZY, Ye QW, Gong WH, Xiang Y, Wan HY. 2010. Humanized monoclonal antibody against the chemokine CXCL-8 (IL-8) effectively prevents acute lung injury. Int Immunopharmacol 10: 259263.
  • Driscoll KE, Costa DL, Hatch G, Henderson R, Oberdorster G, Salem H, Schlesinger RB. 2000. Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: uses and limitations. Toxicol Sci 55: 2435.
  • Geiser T. 2003. Mechanisms of alveolar epithelial repair in acute lung injury—a translational approach. Swiss Med Wkly 133: 586590.
  • Goss CH, Brower RG, Hudson LD, Rubenfeld GD. 2003. Incidence of acute lung injury in the United States. Crit Care Med 31: 16071611.
  • Gupta N, Su X, Popov B, Lee JW, Serikov V, Matthay MA. 2007. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 179: 18551863.
  • Hagiwara S, Iwasaka H, Matsumoto S, Noguchi T. 2008. High dose antithrombin III inhibits HMGB1 and improves endotoxin-induced acute lung injury in rats. Intensive Care Med 34: 361367.
  • Hua F, Ren W, Zhu L. 2011. Plasminogen activator inhibitor type-1 deficiency exaggerates LPS-induced acute lung injury through enhancing Toll-like receptor 4 signaling pathway. Blood Coagul Fibrinolysis 22: 480486.
  • Kim HA, Park JH, Lee S, Choi JS, Rhim T, Lee M. 2011. Combined delivery of dexamethasone and plasmid DNA in an animal model of LPS-induced acute lung injury. J Control Release 156: 6069.
  • Kropski JA, Fremont RD, Calfee CS, Ware LB. 2009. Clara cell protein (CC16), a marker of lung epithelial injury, is decreased in plasma and pulmonary edema fluid from patients with acute lung injury. Chest 135: 14401447.
  • Kurdowska A, Noble JM, Grant IS, Robertson CR, Haslett C, Donnelly SC. 2002. Anti-interleukin-8 autoantibodies in patients at risk for acute respiratory distress syndrome. Crit Care Med 30: 23352337.
  • Kurdowska A, Noble JM, Steinberg KP, Ruzinski JT, Hudson LD, Martin TR. 2001. Anti-interleukin 8 autoantibody: interleukin 8 complexes in the acute respiratory distress syndrome—relationship between the complexes and clinical disease activity. Am J Resp Crit Care 163: 463468.
  • Li B, Dong C, Wang G, Zheng H, Wang X, Bai C. 2011. Pulmonary epithelial CCR3 promotes LPS-induced lung inflammation by mediating release of IL-8. J Cell Physiol 226: 23982405.
  • Lipka J, Semmler-Behnke M, Sperling RA, Wenk A, Takenaka S, Schleh C, Kissel T, Parak WJ, Kreyling WG. 2010. Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. Biomaterials 31: 65746581.
  • Mei SH, McCarter SD, Deng Y, Parker CH, Liles WC, Stewart DJ. 2007. Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med 4: e269.
  • Morimoto Y, Hirohashi M, Ogami A, Oyabu T, Myojo T, Todoroki M, Yamamoto M, Hashiba M, Mizuguchi Y, Lee BW, Kuroda E, Shimada M, Wang WN, Yamamoto K, Fujita K, Endoh S, Uchida K, Kobayashi N, Mizuno K, Inada M, Tao H, Nakazato T, Nakanishi J, Tanaka I. 2011. Pulmonary toxicity of well-dispersed multi-wall carbon nanotubes following inhalation and intratracheal instillation. Nanotoxicology. [Epub ahead of print].
  • Munoz NM, Meliton AY, Meliton LN, Dudek SM, Leff AR. 2009. Secretory group V phospholipase A(2) regulates acute lung injury and neutrophilic inflammation caused by LPS in mice. Am J Physiol Lung C 296: L879L887.
  • Reutershan J, Basit A, Galkina EV, Ley K. 2005. Sequential recruitment of neutrophils into lung and bronchoalveolar lavage fluid in LPS-induced acute lung injury. Am J Physiol Lung C 289: L807L815.
  • Ritter C, da Cunha AA, Echer IC, Andrades M, Reinke A, Lucchiari N, Rocha J, Streck EL, Menna-Barreto S, Moreira JC, Dal-Pizzol F. 2006. Effects of N-acetylcysteine plus deferoxamine in lipopolysaccharide-induced acute lung injury in the rat. Crit Care Med 34: 471477.
  • Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD. 2005. Incidence and outcomes of acute lung injury. N Engl J Med 353: 16851693.
  • Song YL, Fukuda N, Bai CX, Ma TH, Matthay MA, Verkman AS. 2000. Role of aquaporins in alveolar fluid clearance in neonatal and adult lung, and in oedema formation following acute lung injury: studies in transgenic aquaporin null mice. J Physiol Lond 525: 771779.
  • Spragg RG, Bernard GR, Checkley W, Curtis JR, Gajic O, Guyatt G, Hall J, Israel E, Jain M, Needham DM, Randolph AG, Rubenfeld GD, Schoenfeld D, Thompson BT, Ware LB, Young D, Harabin AL. 2010. Beyond mortality: future clinical research in acute lung injury. Am J Respir Crit Care Med 181: 11211127.
  • Su X, Bai CX, Hong QY, Zhu DM, He LX, Wu JP, Ding F, Fang XH, Matthay MA. 2003. Effect of continuous hemofiltration on hemodynamics, lung inflammation and pulmonary edema in a canine model of acute lung injury. Intens Care Med 29: 20342042.
  • Thorley AJ, Ford PA, Giembycz MA, Goldstraw P, Young A, Tetley TD. 2007. Differential regulation of cytokine release and leukocyte migration by lipopolysaccharide-stimulated primary human lung alveolar type II epithelial cells and macrophages. J Immunol 178: 463473.
  • Ware LB, Matthay MA. 2000. The acute respiratory distress syndrome. N Engl J Med 342: 13341349.
  • Xu XL, Xie QM, Shen YH, Jiang JJ, Chen YY, Yao HY, Zhou JY. 2008. Mannose prevents lipopolysaccharide-induced acute lung injury in rats. Inflamm Res 57: 104110.